SPES:LSE:LSE-Invesco S&P 500 Equal Weight Index ETF Inc GBP (GBX)

ETF | Others |

Last Closing

USD 3983.25

Change

+15.00 (+0.38)%

Market Cap

N/A

Volume

909.00

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-04-29 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
0R1O:LSE Amazon.com Inc.

+0.60 (+0.32%)

USD 1,607.29B
LCJD:LSE Amundi MSCI Japan (DR) UCITS E..

+0.13 (+0.72%)

USD 640.06B
LCJP:LSE Lyxor Core MSCI Japan (DR) UCI..

+0.10 (+0.70%)

USD 640.06B
0R1I:LSE NVIDIA Corp.

+2.48 (+2.32%)

USD 618.20B
0R1G:LSE Home Depot Inc.

N/A

USD 373.16B
0QZK:LSE Coca-Cola Co.

+0.35 (+0.49%)

USD 266.08B
PRJU:LSE Amundi Index Solutions - Amund..

+0.24 (+0.77%)

USD 259.48B
0QZO:LSE 0QZO

+0.80 (+0.89%)

USD 258.54B
0QZ3:LSE Qualcomm Inc.

-0.20 (-0.14%)

USD 202.26B
0R24:LSE Intel Corp.

+0.52 (+2.58%)

USD 196.14B

ETFs Containing SPES:LSE

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -10.40% 17% F 26% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -10.40% 17% F 26% F
Trailing 12 Months  
Capital Gain -3.40% 22% F 37% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -3.40% 20% F 36% F
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain 6.40% 52% F 58% F
Dividend Return 6.40% 51% F 57% F
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 7.94% 73% C 86% B+
Risk Adjusted Return 80.61% 79% B- 87% B+
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (GBX)

Quarterly Financials (GBX)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:

There is nothing we particularly dislike